ANDEM draws up French guidelines for 1996:
This article was originally published in Clinica
Executive Summary
French research agency ANDEM has drawn up the first series of medical guidelines for 1996. The agency was asked to draft recommendations for 23 subjects to add to the 147 guidelines in existence. The series is out for comment with French medical insurers and doctors' unions. The first additional guidelines for 1996 will include regular check-ups for pregnant women, including testing for hepatitis B and C, rubella and syphilis.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.